<?xml version="1.0" encoding="UTF-8"?>
<ref id="B35">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chono</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Katsumata</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kontani</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kobayashi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sudo</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Yokota</surname>
    <given-names>T.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2010</year>). 
  <article-title>ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.</article-title>
  <source>
   <italic>J. Antimicrob. Chemother.</italic>
  </source>
  <volume>65</volume>
  <fpage>1733</fpage>â€“
  <lpage>1741</lpage>. 
  <pub-id pub-id-type="doi">10.1093/jac/dkq198</pub-id>
  <?supplied-pmid 20534624?>
  <pub-id pub-id-type="pmid">20534624</pub-id>
 </mixed-citation>
</ref>
